Follow
loic dupre
loic dupre
Research scientist, INSERM, Toulouse, France
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation
L Dupré, A Aiuti, S Trifari, S Martino, P Saracco, C Bordignon, ...
Immunity 17 (2), 157-166, 2002
2402002
A proportion of patients with lymphoma may harbor mutations of the perforin gene
R Clementi, F Locatelli, L Dupré, A Garaventa, L Emmi, M Bregni, ...
Blood 105 (11), 4424-4428, 2005
2212005
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells
CS Ma, NJ Hare, KE Nichols, L Dupré, G Andolfi, MG Roncarolo, ...
The Journal of clinical investigation 115 (4), 1049-1059, 2005
2122005
SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells
L Dupré, G Andolfi, SG Tangye, R Clementi, F Locatelli, M Arico, A Aiuti, ...
Blood 105 (11), 4383-4389, 2005
2072005
WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells
F Marangoni, S Trifari, S Scaramuzza, C Panaroni, S Martino, ...
The Journal of experimental medicine 204 (2), 369-380, 2007
2052007
Collective cell motility promotes chemotactic prowess and resistance to chemorepulsion
G Malet-Engra, W Yu, A Oldani, J Rey-Barroso, NS Gov, G Scita, L Dupré
Current Biology 25 (2), 242-250, 2015
1552015
Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments
C Cougoule, E Van Goethem, V Le Cabec, F Lafouresse, L Dupré, ...
European journal of cell biology 91 (11-12), 938-949, 2012
1382012
DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma
R Amin, F Mourcin, F Uhel, C Pangault, P Ruminy, L Dupré, M Guirriec, ...
Blood, The Journal of the American Society of Hematology 126 (16), 1911-1920, 2015
1372015
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients
S Charrier, L Dupre, S Scaramuzza, L Jeanson-Leh, MP Blundell, ...
Gene therapy 14 (5), 415-428, 2007
1362007
Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients
S Trifari, G Sitia, A Aiuti, S Scaramuzza, F Marangoni, LG Guidotti, ...
The Journal of Immunology 177 (10), 7451-7461, 2006
1332006
Lentiviral vector-mediated gene transfer in T cells from Wiskott–Aldrich syndrome patients leads to functional correction
L Dupré, S Trifari, A Follenzi, F Marangoni, TL De Lera, A Bernad, ...
Molecular Therapy 10 (5), 903-915, 2004
1312004
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics
E Salzer, D Cagdas, M Hons, EM Mace, W Garncarz, ÖY Petronczki, ...
Nature immunology 17 (12), 1352-1360, 2016
1292016
T lymphocyte migration: an action movie starring the actin and associated actors
L Dupré, R Houmadi, C Tang, J Rey-Barroso
Frontiers in immunology 6, 164898, 2015
1192015
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation
L Dupré, F Marangoni, S Scaramuzza, S Trifari, RJ Hernández, A Aiuti, ...
Human gene therapy 17 (3), 303-313, 2006
1142006
An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte/target cell synapse
F Bertrand, S Müller, KH Roh, C Laurent, L Dupré, S Valitutti
Proceedings of the National Academy of Sciences 110 (15), 6073-6078, 2013
1132013
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency
I Brigida, M Zoccolillo, MP Cicalese, L Pfajfer, F Barzaghi, S Scala, ...
Blood, The Journal of the American Society of Hematology 132 (22), 2362-2374, 2018
1082018
Evidence for long-term efficacy and safety of gene therapy for Wiskott–Aldrich syndrome in preclinical models
F Marangoni, M Bosticardo, S Charrier, E Draghici, M Locci, ...
Molecular Therapy 17 (6), 1073-1082, 2009
1072009
Eomes-dependent loss of the co-activating receptor CD226 restrains CD8+ T cell anti-tumor functions and limits the efficacy of cancer immunotherapy
M Weulersse, A Asrir, AC Pichler, L Lemaitre, M Braun, N Carrié, ...
Immunity 53 (4), 824-839. e10, 2020
982020
Single-Dose Mucosal Immunization with Biodegradable Microparticles Containing a Schistosoma mansoniAntigen
B Baras, MA Benoit, L Dupré, O Poulain-Godefroy, AM Schacht, A Capron, ...
Infection and immunity 67 (5), 2643-2648, 1999
981999
CpG motifs induce Langerhans cell migration in vivo
E Ban, L Dupré, E Hermann, W Rohn, C Vendeville, B Quatannens, ...
International immunology 12 (6), 737-745, 2000
952000
The system can't perform the operation now. Try again later.
Articles 1–20